Kailera Therapeutics, Inc. (KLRA)
16.21
-2.32
(-12.52%)
USD |
NASDAQ |
Aug 28, 16:00
16.50
+0.29
(+1.79%)
After-Hours: 20:00
Kailera Therapeutics Cash from Operations (Quarterly) : -77.53M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -77.53M |
| Date | Value |
|---|---|
| March 31, 2026 | -68.31M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Moderna, Inc. | -526.00M |
| Revolution Medicines, Inc. | -387.32M |
| Sana Biotechnology, Inc. | -32.79M |
| Parabilis Medicines, Inc. | -3.622M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -571.02M |
| Cash from Financing (Quarterly) | 667.03M |
| Free Cash Flow Per Share (Quarterly) | -0.5981 |
| Free Cash Flow to Equity (Quarterly) | -77.27M |
| Free Cash Flow to Firm (Quarterly) | -77.53M |